132 related articles for article (PubMed ID: 15816548)
21. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues.
Eigeliene N; Härkönen P; Erkkola R
Cell Cycle; 2008 Jan; 7(1):71-80. PubMed ID: 18196959
[TBL] [Abstract][Full Text] [Related]
22. Oncogene amplification and overexpression of oncoproteins in thyroid papillary cancer.
Várkondi E; Gyory F; Nagy A; Kiss I; Ember I; Kozma L
In Vivo; 2005; 19(2):465-70. PubMed ID: 15796211
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients.
Hwang TS; Han HS; Hong YC; Lee HJ; Paik NS
Pathol Int; 2003 Feb; 53(2):74-80. PubMed ID: 12588434
[TBL] [Abstract][Full Text] [Related]
24. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
[TBL] [Abstract][Full Text] [Related]
25. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database.
Morris GJ; Naidu S; Topham AK; Guiles F; Xu Y; McCue P; Schwartz GF; Park PK; Rosenberg AL; Brill K; Mitchell EP
Cancer; 2007 Aug; 110(4):876-84. PubMed ID: 17620276
[TBL] [Abstract][Full Text] [Related]
26. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
[TBL] [Abstract][Full Text] [Related]
27. Protein expression patterns of cell cycle regulators in operable breast cancer.
Zagouri F; Kotoula V; Kouvatseas G; Sotiropoulou M; Koletsa T; Gavressea T; Valavanis C; Trihia H; Bobos M; Lazaridis G; Koutras A; Pentheroudakis G; Skarlos P; Bafaloukos D; Arnogiannaki N; Chrisafi S; Christodoulou C; Papakostas P; Aravantinos G; Kosmidis P; Karanikiotis C; Zografos G; Papadimitriou C; Fountzilas G
PLoS One; 2017; 12(8):e0180489. PubMed ID: 28797035
[TBL] [Abstract][Full Text] [Related]
28. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
[TBL] [Abstract][Full Text] [Related]
29. Hormone receptors in breast cancer: racial differences in distribution and survival.
Joslyn SA
Breast Cancer Res Treat; 2002 May; 73(1):45-59. PubMed ID: 12083631
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors.
Al-Abbadi MA; Washington TA; Saleh HA; Tekyi-Mensah SE; Lucas DR; Briston CA
Breast Cancer Res Treat; 2006 May; 97(1):3-8. PubMed ID: 16432664
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer.
Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237
[TBL] [Abstract][Full Text] [Related]
32. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
33. Race and the prognostic influence of p53 in women with breast cancer.
Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
[TBL] [Abstract][Full Text] [Related]
34. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.
Mehrotra J; Ganpat MM; Kanaan Y; Fackler MJ; McVeigh M; Lahti-Domenici J; Polyak K; Argani P; Naab T; Garrett E; Parmigiani G; Broome C; Sukumar S
Clin Cancer Res; 2004 Mar; 10(6):2052-7. PubMed ID: 15041725
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma.
El-Hafez AA; El Aaty Shawky A; Hasan B
Cancer Biomark; 2012; 12(4):149-54. PubMed ID: 23568005
[TBL] [Abstract][Full Text] [Related]
37. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis focused on cell cycle regulation.
Senkus E; Szade J; Pieczyńska B; Kunc M; Pliszka A; Jassem J
Histol Histopathol; 2018 Jan; 33(1):55-64. PubMed ID: 28276034
[TBL] [Abstract][Full Text] [Related]
38. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics.
Jones BA; Kasl SV; Howe CL; Lachman M; Dubrow R; Curnen MM; Soler-Vila H; Beeghly A; Duan F; Owens P
Cancer; 2004 Sep; 101(6):1293-301. PubMed ID: 15368321
[TBL] [Abstract][Full Text] [Related]
39. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Elledge RM; Clark GM; Chamness GC; Osborne CK
J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
[TBL] [Abstract][Full Text] [Related]
40. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
